DD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Dupont De Nemours Inc (DD) is not a strong buy for a beginner investor with a long-term strategy at this moment. While the company has shown some positive developments, such as exceeding Q4 expectations and projecting strong 2026 earnings, the recent price decline (-4.08% in regular market trading) and mixed financial performance, including a significant YoY revenue drop, suggest caution. Additionally, there are no strong proprietary trading signals or significant catalysts to justify immediate investment.
The technical indicators are mixed. The MACD is positive but contracting, RSI is neutral, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support and resistance levels indicate a pivot at 47.629, with resistance at 51.285 and support at 43.974. The stock has a 50% chance of slight declines in the short term, with a -2.13% probability over the next month.
DuPont's Q4 revenue exceeded expectations, and EPS rose 18% YoY to $0.
The company completed the spin-off of its electronics business, leading to a 40% stock increase since the event.
DuPont announced a $2 billion share repurchase authorization.
Analysts have raised price targets, with several maintaining Buy or Outperform ratings.
Revenue dropped significantly in 2025/Q4 (-45.25% YoY).
Gross margin decreased slightly (-1.58% YoY).
The stock declined by -4.08% in regular market trading, reflecting potential short-term weakness.
Broader market conditions are bearish, with the S&P 500 down -1.54%.
In 2025/Q4, revenue dropped significantly (-45.25% YoY) to $1.693 billion. However, net income improved by 6.78% YoY, and EPS increased by 7.14% YoY to -0.3. Gross margin slightly decreased to 31.13%. The company generated $87 million in cash from operating activities and achieved a transaction-adjusted free cash flow of $228 million. DuPont projects 2026 sales between $7.075 billion and $7.135 billion, with EPS of $2.25 to $2.30, ahead of analysts' expectations.
Analysts are generally positive on DuPont, with multiple firms raising price targets recently. Notable ratings include Mizuho ($52), Citi ($59), and UBS ($56), all maintaining Buy or Outperform ratings. However, some analysts have expressed concerns about structural issues in the chemical industry, such as cyclical downturns and tariff risks.
